Clinical efficacy of Coleus forskohlii (Willd.) Briq. (Makandi) in XXXX of geriatric population.

@entity1 @entity101 @entity146 @entity5539 @entity551
@entity101 is the most common @entity5539 affecting 972 million @entity1 worldwide. The present clinical study deals with the effect of Makandi (Coleus forskohlii (Willd.) Briq.) Ghana vati and tablets of its powder in @entity101 found in the geriatric age group (50-80 years). A total of 49 @entity101 @entity1 fulfilling the diagnostic criteria were registered in two groups-Group I (Ghana vati) and Group II (Churna tablet). Out of 27 enrolled @entity1 of group I, 21 @entity1 completed the treatment. In Group II, out of 22 registered @entity1 , a total of 20 @entity1 completed the treatment. The effect of the therapy was assessed on the basis of changes in the @entity551 , in both sitting and supine positions; with Manasa Bhava Pariksha, Manasa Vibhrama Pariksha, symptomatology, geriatric signs and symptoms, and a brief @entity146 rating scale. Analysis of the results showed that the treatment in both the groups had been found to be good. It can be stated that Makandi, either in Ghana vati form or in churna tablet form, is an effective remedy for the treatment of @entity101 . On analyzing the overall effect, 76.19% @entity1 in Group I and 75.00% @entity1 in Group II were mildly improved. Comparatively the overall treatment with group I was found to be better.
